Treatment of metastatic pancreatic adenocarcinoma - A comprehensive review

Authors
Kozuch, P Petryk, M Evans, A Bruckner, HW
Citation
P. Kozuch et al., Treatment of metastatic pancreatic adenocarcinoma - A comprehensive review, SURG CL NA, 81(3), 2001, pp. 683
Citations number
51
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
SURGICAL CLINICS OF NORTH AMERICA
ISSN journal
00396109 → ACNP
Volume
81
Issue
3
Year of publication
2001
Database
ISI
SICI code
0039-6109(200106)81:3<683:TOMPA->2.0.ZU;2-E
Abstract
Significant advances have been made with chemotherapy for metastatic pancre atic cancer. Quality of life and survival are increasing. Gemcitabine has p rompted a generation of phase II trails alone and in combination. Two, thre e, and four drug gemcitabine-based combinations have response rates greater than 20% and median survival rates of 8 or more months.